Gilead Sciences Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 6.29, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Gilead Sciences Inc in Sep 30 2026 quarter, has decreased to 58 days, compared to 59 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 286 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2191, from overall ranking in the second quarter 2026 at 2495.

What is Receivable Turnover Ratio?
What is Gilead Sciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GILD Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	-1.73 %	5.73 %	8.04 %	11.15 %	11.07 %
Y / Y Revenue Change	6.83 %	10.18 %	4.39 %	4.7 %	2.97 %
Receivable Turnover Ratio (TTM)	6.29	6.15	6.09	6.14	6.23
GILD's Total Ranking	# 2191	# 2495	# 2194	# 2188	# 2225
Accounts Receivable average collection period days	58	59	60	59	59
Seq. Receivable Change	-0.95 %	6.62 %	-3.5 %	-3.57 %	6.57 %
Seq. Revenue Change	6.37 %	12.11 %	-12.18 %	2.01 %	9.7 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 28
Healthcare Sector	# 287
Overall Market	# 2191

Receivable Turnover Ratio Statistics
High	Average	Low
7.12	5.87	4.41
(Sep. 30, 2014)		(March 31, 2012)

GILD Company Profile • Back to GILD Efficiency Comparisons • Compare GILD Receivables Turnover Ratio to its Competitors

Financial Statements
Gilead Sciences Inc 's Accounts Receivable	$ 5,007 Millions	Visit GILD's Balance sheet
Gilead Sciences Inc 's Sales TTM	$ 30,988 Millions	Visit GILD's Income Statement
Sources of GILD's Revenues		Visit GILD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GILD's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GILD's Growth Rates	GILD's Roa	GILD's Inventory Turnover Ratio	GILD's Dividend Comparisons
GILD's Profitability Ratios	GILD's Roi	GILD's Asset Turnover Ratio	GILD's Dividend Growth
GILD's Valuation Ratios	GILD's Roe	GILD's Financial Strength Ratios	GILD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Biogen Inc	15.19	$ 10,297.300 Millions	$ 677.900 Millions
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Hca Healthcare Inc	6.85	$ 78,701.000 Millions	$ 11,495.250 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
Carlisle Companies Incorporated	6.67	$ 5,213.500 Millions	$ 781.625 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions
Baxter International Inc	6.55	$ 11,784.000 Millions	$ 1,799.500 Millions
Healthcare Services Group Inc	6.36	$ 1,879.860 Millions	$ 295.784 Millions
Integra Lifesciences Holdings Corp	6.26	$ 1,656.786 Millions	$ 264.861 Millions
Neogen Corporation	6.17	$ 884.120 Millions	$ 143.371 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions

Date modified: 2026-10-31T08:48:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.